부산대학교 도서관

Roussel, M; Moreau, P; Hebraud, B; Laribi, K; Jaccard, A; Dib, M; Slama, B; Dorvaux, V; Royer, B; Frenzel, L; Zweegman, S; Klein, SK; Broijl, A.; Jie, KS; Wang, J; Vanquickelberghe, V; Boer, C; Kampfenkel, T; Gries, KS; Fastenau, J; Sonneveld, Pieter

The Lancet Haematology. 7(12):874-883

Quaife, M; Jimenez-Moreno, C; Otero B, Gros; Asra, A; Gupta-Werner, N; Gries, KS; Leisten, MK; Matt, K; Carson, R; Dennis, R; He, J; Levitan, B; Bathija, S

Value in Health. 27(6):S322-S322

Mateos, MV; Cohen, AD; Cohen, YC; Agha, M; San-Miguel, J.; Richard, S; van de Donk, NWCJ; Champlain A, De; Katz, EG; Iaconangelo, C; Braganca KC, De; Schecter, JM; Varsos, H; Corsale, C; Deraedt, W; Koneru, M; Filho O, Costa; Akram, M; Gries, KS

Value in Health. 27(6):S320-S320

Schinke, C; Touzeau, C; Oriol, A; Mateos, MV; Stevens, DA; Rasche, L; Qin, X; Kato, K; Ming, T; Katz, EG; Gries, KS; Campagna, M; Masterson, TJ; Hilder, BW; Tolbert, J; Renaud, T; Heuck, C; Moreau, P; San-Miguel, J; Otero, PR; Chari, A

Blood
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)

Silbermann R; Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.; Laubach J; Department of Medical Oncology, Dana-Farber/Partners Cancer Care, Boston, Massachusetts, USA.; Kaufman JL; Department of Mematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.; Sborov DW; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, USA.; Reeves B; Division of Hematology, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, USA.; Rodriguez C; Department of Hematology and Medical Oncology, Mount Sinai School of Medicine, New York, New York, USA.; Chari A; Department of Hematology and Medical Oncology, Mount Sinai School of Medicine, New York, New York, USA.; Costa LJ; Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA.; Anderson LD Jr; Division of Hematology/Oncology, Simmons Comprehensive Cancer Center, UT Texas Southwestern Medical Center, Dallas, Texas, USA.; Nathwani N; Division of Myeloma, Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA.; Shah N; Department of Medicine, University of California San Francisco, San Francisco, California, USA.; Bumma N; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.; Holstein SA; Division of Oncology and Hematology, University of Nebraska Medical Center, Omaha, Nebraska, USA.; Costello C; Division of Blood and Marrow Transplantation, Moores Cancer Center, University of California San Diego, La Jolla, California, USA.; Jakubowiak A; Medicine- Hematology and Oncology, University of Chicago, Chicago, Illinois, USA.; Orlowski RZ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Shain KH; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.; Cowan AJ; Department of Medicine, University of Washington, Seattle, Washington, USA.; Gries KS; Janssen Research & Development, Raritan, New Jersey, USA.; Pei H; Janssen Research & Development, LLC, Titusville, New Jersey, USA.; Cortoos A; Janssen Scientific Affairs, LLC, Horsham, Pennsylvania, USA.; Patel S; Janssen Scientific Affairs, LLC, Horsham, Pennsylvania, USA.; Lin TS; Janssen Scientific Affairs, LLC, Horsham, Pennsylvania, USA.; Voorhees PM; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health/Wake Forest University School of Medicine, Charlotte, North Carolina, USA.; Usmani SZ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Richardson PG; Department of Medical Oncology, Dana-Farber/Partners Cancer Care, Boston, Massachusetts, USA.

Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

Schinke C; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.; Touzeau C; Centre Hospitalier Universitaire de Nantes, Nantes, France.; Oriol A; Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain.; Mateos MV; Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca, Centro de Investigación del Cáncer, IBMCC-USAL, CSIC, Salamanca, Spain.; Stevens D; Norton Cancer Institute, Louisville, Kentucky, USA.; Rasche L; University Hospital of Würzburg, Würzburg, Germany.; Qin X; Johnson & Johnson, Spring House, Pennsylvania, USA.; Kato K; Johnson & Johnson, Raritan, New Jersey, USA.; Bathija S; Johnson & Johnson, Raritan, New Jersey, USA.; Katz EG; Johnson & Johnson, Raritan, New Jersey, USA.; Gries KS; Johnson & Johnson, Raritan, New Jersey, USA.; Campagna M; Johnson & Johnson, Madrid, Spain.; Masterson T; Johnson & Johnson, Spring House, Pennsylvania, USA.; Hilder BW; Johnson & Johnson, Spring House, Pennsylvania, USA.; Tolbert J; Johnson & Johnson, Spring House, Pennsylvania, USA.; Renaud T; Johnson & Johnson, Raritan, New Jersey, USA.; Heuck C; Johnson & Johnson, Spring House, Pennsylvania, USA.; Tomlinson C; Johnson & Johnson, Raritan, New Jersey, USA.; Moreau P; University Hospital Hotel-Dieu, Nantes, France.; San-Miguel J; Cancer Center Clínica Universidad de Navarra, CIMA, CIBERONC, IDISNA, Pamplona, Spain.; Rodríguez-Otero P; Cancer Center Clínica Universidad de Navarra, CIMA, CIBERONC, IDISNA, Pamplona, Spain.; Chari A; Multiple Myeloma Program, University of California San Francisco, San Francisco, California, USA.

Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

Martin TG; University of California San Francisco, San Francisco, CA. Electronic address: Tom.Martin@ucsf.edu.; Moreau P; Hematology Clinic, University Hospital Hôtel-Dieu, Nantes, France.; Usmani SZ; Levine Cancer Institute/Atrium Health, Charlotte, NC.; Garfall A; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Mateos MV; University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain.; San-Miguel JF; Clínica Universidad de Navarra (CCUN), CIMA, CIBERONC, IDISNA, Pamplona, Spain.; Oriol A; Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain.; Nooka AK; Winship Cancer Institute, Emory University, Atlanta, GA.; Rosinol L; Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.; Chari A; Mount Sinai School of Medicine, New York, NY.; Karlin L; Service d'Hématologie Clinique, Centre Hospitalier Lyon Sud, Pierre-Bénite, France.; Krishnan A; City of Hope Comprehensive Cancer Center, Duarte, CA.; Bahlis N; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.; Popat R; University College London Hospitals, NHS Foundation Trust, London, UK.; Besemer B; University of Tuebingen, Tuebingen, Germany.; Martínez-López J; Haematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, CNIO, CIBERONC, Madrid, Spain.; Delforge M; Universitaire Ziekenhuizen Leuven, Leuven, Belgium.; Trancucci D; Janssen Research & Development, Raritan, NJ.; Pei L; Janssen Research & Development, Raritan, NJ.; Kobos R; Janssen Research & Development, Raritan, NJ.; Fastenau J; Janssen Research & Development, Raritan, NJ.; Gries KS; Janssen Research & Development, Raritan, NJ.; van de Donk NWCJ; Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

Perrot A; Facon T; Plesner T; Usmani SZ; Kumar S; Bahlis NJ; Hulin C; Orlowski RZ; Nahi H; Mollee P; Ramasamy K; Roussel M; Jaccard A; Delforge M; Karlin L; Arnulf B; Chari A; He J; Ho KF; Van Rampelbergh R; Uhlar CM; Wang J; Kobos R; Gries KS; Fastenau J; Weisel K

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE; PubMed not MEDLINE

Perrot A; Centre Hospitalier Universitaire de Toulouse, Service d'Hématologie, Toulouse, France.; Facon T; University of Lille, CHU Lille, Lille, France.; Plesner T; Vejle Hospital and University of Southern Denmark, Vejle, Denmark.; Usmani SZ; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Kumar S; Mayo Clinic, Rochester, Minnesota, USA.; Bahlis NJ; University of Calgary, Arnie Charbonneau Cancer Research Institute, Calgary, Alberta, Canada.; Hulin C; Hôpital Haut Leveque, University Hospital, Pessac, France.; Orlowski RZ; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Nahi H; Karolinska University Hospital at Huddinge, Stockholm, Sweden.; Mollee P; Princess Alexandra Hospital and University of Queensland Medical School, Brisbane, Queensland, Australia.; Ramasamy K; Oxford University Hospitals, NHS Foundation Trust, Oxford, UK.; Roussel M; Centre Hospitalier Universitaire, Limoges, France.; Jaccard A; Centre Hospitalier Universitaire, Limoges, France.; Delforge M; University Hospital Leuven, Leuven, Belgium.; Karlin L; Centre Hospitalier Lyon Sud, Pierre-Bénite, France.; Arnulf B; Immuno-Hématologie, Hospital Saint Louis, APHP, Paris, France.; Chari A; Mount Sinai School of Medicine, New York, New York, USA.; Wang G; Johnson & Johnson, Spring House, Pennsylvania, USA.; Gupta-Werner N; Johnson & Johnson, Horsham, Pennsylvania, USA.; Kaila S; Johnson & Johnson, Horsham, Pennsylvania, USA.; Pei H; Johnson & Johnson, Titusville, New Jersey, USA.; Matt K; Johnson & Johnson, Raritan, New Jersey, USA.; Gries KS; Johnson & Johnson, Raritan, New Jersey, USA.; Carson R; Johnson & Johnson, Raritan, New Jersey, USA.; Borgsten F; Johnson & Johnson, Raritan, New Jersey, USA.; Weisel K; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609 (Electronic) Linking ISSN: 09024441 NLM ISO Abbreviation: Eur J Haematol Subsets: MEDLINE

Martin, TG; Moreau, P; Usmani, SZ; Garfall, AL; Mateos, MV; San-Miguel, JF; Rocafiguera, AO; Nooka, AK; Rosinol, L; Chari, A; Karlin, L; Krishnan, AY; Bahlis, NJ; Popat, R; Besemer, B; Martinez, J; Delforge, M; Fastenau, J; Gries, KS; van de Donk, NWC

JOURNAL OF CLINICAL ONCOLOGY
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)

Mateos MV; University Hospital of Salamanca/IBSAL/Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain.; Rigaudeau S; Hôpital Andre Mignot, Service d'Hematologie et d'Oncologie, Le Chesnay, France.; Basu S; Royal Wolverhampton Hospitals NHS Trust and University, Wolverhampton, UK.; Spicka I; Clinical Department of Haematology, 1st Medical Department, Charles University in Prague, Prague, Czech Republic.; Schots R; UZ Brussel-VUB, Brussels, Belgium.; Wrobel T; Uniwersytet Medyczny we Wrocławiu, Wroclaw, Poland.; Cook G; Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust and University of Leeds, Leeds, UK.; Beksac M; Department of Hematology, Ankara University, Ankara, Turkey.; Gries KS; Janssen Global Services, Raritan, NJ, USA.; Kudva A; Janssen Research & Development, LLC, Raritan, NJ, USA.; Tromp B; Janssen Research & Development, Leiden, The Netherlands.; Van Rampelbergh R; Janssen Research & Development, Beerse, Belgium.; Pei H; Janssen Research & Development, LLC, Titusville, NJ, USA.; Wroblewski S; Janssen Research & Development, LLC, Spring House, PA, USA.; Carson R; Janssen Research & Development, LLC, Spring House, PA, USA.; Delioukina M; Janssen Research & Development, LLC, Spring House, PA, USA.; White D; Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada.

Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE

Terpos, E; Dimopoulos, MA; Boccadoro, M; Delimpasi, S; Beksac, M; Katodritou, E; Moreau, P; Baldini, L; Symeonidis, A; Bila, J; Oriol, A; Mateos, MV; Einsele, H; Orfanidis, I; Gries, KS; Fastenau, J; Kampfenkel, T; Qiu, YP; Amin, H; Sonneveld, P

JOURNAL OF CLINICAL ONCOLOGY
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
Journal of Clinical Oncology
instname

Mina R; Division of Hematology, Azienda Ospedaliero Universitaria Cittá della Salute e della Scienza di Torino, Torino, Italy. Electronic address: roberto.mina.rm@gmail.com.; Mylin AK; Department of Haematology, Rigshospitalet, Copenhagen, Denmark.; Yokoyama H; Department of Hematology, Tohoku University Graduate School of Medicine, Sendai, Japan.; Magen H; Chaim Sheba Medical Center, Ramat-Gan, Israel; Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.; Alsdorf W; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Minnema MC; University Medical Center Utrecht, Utrecht, Netherlands.; Shune L; The University of Kansas Medical Center, Kansas City, KS, USA.; Isufi I; Department of Internal Medicine, Yale School of Medicine, Yale University, New Haven, CT, USA.; Harrison SJ; Peter MacCallum Cancer Centre, Melbourne, Australia.; Shah UA; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.; Schecter JM; Janssen Research & Development, Raritan, NJ, USA.; Vogel M; Janssen Global Services, Raritan, NJ, USA.; Lendvai N; Janssen Research & Development, Raritan, NJ, USA.; Gries KS; Janssen Global Services, Raritan, NJ, USA.; Katz EG; Janssen Global Services, Raritan, NJ, USA.; Slaughter A; Cilag GmbH International, Zug, Switzerland.; Lonardi C; Janssen, Buenos Aires, Argentina.; Gilbert J; Janssen Research & Development, High Wycombe, UK.; Li Q; Janssen Research & Development, Apex, NC, USA.; Deraedt W; Janssen Research & Development, Beerse, Belgium.; Filho OC; Legend Biotech USA, Somerset, NJ, USA.; Patel N; Legend Biotech USA, Somerset, NJ, USA.; Florendo E; Legend Biotech USA, Somerset, NJ, USA.; Karlin L; Centre Hospitalier Lyon Sud, Pierre-Bénite, France.; Weisel K; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE

Voorhees PM; Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC, USA.; Sborov DW; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Laubach J; Dana-Farber/Partners CancerCare, Harvard Medical School, Boston, MA, USA.; Kaufman JL; Winship Cancer Institute, Emory University, Atlanta, GA, USA.; Reeves B; Department of Medicine, University of North Carolina Chapel Hill, Chapel Hill, NC, USA.; Rodriguez C; Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Silbermann R; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.; Costa LJ; University of Alabama at Birmingham Hospital, Birmingham, AL, USA.; Anderson LD Jr; Myeloma, Waldenstrom's & Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.; Nathwani N; Judy & Bernard Briskin Center for Multiple Myeloma Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.; Shah N; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.; Bumma N; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.; Efebera YA; OhioHealth, Blood & Marrow Transplant, Columbus, OH, USA.; Holstein SA; Division of Oncology & Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA.; Costello C; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.; Jakubowiak A; University of Chicago Medical Center, Chicago, IL, USA.; Wildes TM; Division of Oncology & Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA.; Orlowski RZ; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Shain KH; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.; Cowan AJ; Division of Medical Oncology, University of Washington, Seattle, WA, USA.; Dinner S; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.; Gries KS; Janssen Research & Development, LLC, Raritan, NJ, USA.; Pei H; Janssen Research & Development, LLC, Titusville, NJ, USA.; Cortoos A; Janssen Scientific Affairs, LLC, a Johnson & Johnson company, Horsham, PA, USA.; Patel S; Janssen Scientific Affairs, LLC, a Johnson & Johnson company, Horsham, PA, USA.; Lin TS; Janssen Scientific Affairs, LLC, a Johnson & Johnson company, Horsham, PA, USA.; Usmani SZ; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Richardson PG; Dana-Farber/Partners CancerCare, Harvard Medical School, Boston, MA, USA.

Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE; In Process

Cohen AD; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Hari P; Medical College of Wisconsin, Milwaukee, WI.; Htut M; City of Hope Comprehensive Cancer Center, Duarte, CA.; Berdeja JG; Sarah Cannon Research Institute, Nashville, TN.; Usmani SZ; Memorial Sloan Cancer Center, New York, NY.; Madduri D; Janssen Research & Development, Raritan, NJ.; Olyslager Y; Janssen Research & Development, Beerse, Belgium.; Goldberg JD; Janssen Research & Development, Raritan, NJ.; Schecter JM; Janssen Research & Development, Raritan, NJ.; Jackson CC; Janssen Research & Development, Raritan, NJ.; Gries KS; Janssen Research & Development, Raritan, NJ.; Fastenau JM; Janssen Research & Development, Raritan, NJ.; Valluri S; Janssen Global Services, Raritan, NJ.; Deraedt W; Janssen Research & Development, Beerse, Belgium.; Akram M; Legend Biotech USA, Piscataway, NJ.; Crawford R; RTI Health Solutions, Manchester, UK.; Morrison R; RTI Health Solutions, Manchester, UK.; Doward L; RTI Health Solutions, Manchester, UK.; Morgan K; Myeloma Patients Europe, Brussels, Belgium.; Seldam ST; Myeloma Patients Europe, Brussels, Belgium.; Jakubowiak A; University of Chicago, Chicago, IL.; Jagannath S; Mount Sinai Medical Center, New York, NY. Electronic address: sundar.jagannath@mountsinai.com.

Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

Crawford R; RTI Health Solutions, Manchester, UK.; Gries KS; Janssen Global Services, LLC, Raritan, NJ, USA.; Valluri S; Janssen Global Services, LLC, Raritan, NJ, USA.; Fastenau J; Janssen Global Services, LLC, Raritan, NJ, USA.; Morrison R; RTI Health Solutions, Manchester, UK.; Yeh TM; Janssen Global Services, LLC, Raritan, NJ, USA.; Olyslager Y; Janssen Global Services, LLC, Raritan, NJ, USA.; Goldberg JD; Janssen Global Services, LLC, Raritan, NJ, USA.; Schecter JM; Janssen Global Services, LLC, Raritan, NJ, USA.; Jackson CC; Janssen Global Services, LLC, Raritan, NJ, USA.; Deraedt W; Janssen Global Services, LLC, Raritan, NJ, USA.; Doward L; RTI Health Solutions, Manchester, UK.

Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101747728 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2573-8348 (Electronic) Linking ISSN: 25738348 NLM ISO Abbreviation: Cancer Rep (Hoboken) Subsets: MEDLINE

Sanchorawala V; Amyloidosis Center, Department of Hematology, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.; Palladini G; Department of Molecular Medicine, University of Pavia, Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.; Minnema MC; Department of Hematology, University Medical Center Utrecht, Utrecht, Netherlands.; Jaccard A; Service d'hématologie clinique et de thérapie cellulaire, CHU de Limoges, Limoges, France.; Lee HC; Department of Lymphoma and Myeloma, Division of Cancer Medicine, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.; Gibbs S; The Victorian and Tasmanian Amyloidosis Service, Department of Haematology, Monash University Eastern Health Clinical School, Box Hill, Victoria, Australia.; Mollee P; Department of Hematology, Princess Alexandra Hospital and University of Queensland Medical School, Brisbane, Queensland, Australia.; Venner C; Cross Cancer Institute, Alberta Health Services, Edmonton, Alberta, Canada.; Lu J; Institute of Hematology, Peking University People's Hospital, Beijing, China.; Schönland S; Amyloidosis Center, Universitaetsklinikum Heidelberg Medizinische Klinik V, Heidelberg, Germany.; Gatt M; Hematology Department, Hadassah Medical Center, Jerusalem, Israel.; Suzuki K; Department of Hematology, Japanese Red Cross Central Medical Center, Shibuya, Tokyo, Japan.; Kim K; Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, South Korea.; Cibeira MT; Amyloidosis and Myeloma Unit, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain.; Beksac M; Department of Hematology, Ankara University, Ankara, Turkey.; Libby E; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington, USA.; Valent J; Department of Hematology and Medical Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio, USA.; Hungria V; Department of Hematology, Clinica São Germano, São Paulo, Brazil.; Wong SW; UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.; Rosenzweig M; Department of Hematology and Hematopoietic Cell Transplantation, Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, California, USA.; Bumma N; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.; Chauveau D; Centre de Référence des Maladies Rénales Rares, Département de Néphrologie et Transplantation d'Organes, CHU de Toulouse, Toulouse, France.; Gries KS; Janssen Research & Development, LLC, Raritan, New Jersey, USA.; Fastenau J; Janssen Research & Development, LLC, Raritan, New Jersey, USA.; Tran NP; Janssen Research & Development, LLC, Los Angeles, California, USA.; Qin X; Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.; Vasey SY; Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.; Weiss BM; Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.; Vermeulen J; Janssen Research & Development, LLC, Leiden, Netherlands.; Ho KF; STAT-TU Inc., Elora, Ontario, Canada.; Merlini G; Department of Molecular Medicine, University of Pavia, Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.; Comenzo RL; Division of Hematology/Oncology, John C. Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, Massachusetts, USA.; Kastritis E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.; Wechalekar AD; Clinical Haematology, Cancer Division, University College Hospital, London, England, UK.

Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

Terpos E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.; Dimopoulos MA; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.; Boccadoro M; Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy.; Delimpasi S; Department of Hematology, Evangelismos Hospital, Athens, Greece.; Beksac M; Department of Hematology, Ankara University, Ankara, Turkey.; Katodritou E; Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, Greece.; Moreau P; Hematology Department, University Hospital Hôtel-Dieu, Nantes, France.; Pompa A; Hematology Unit, University of Milan, Milan, Italy.; Symeonidis A; Department of Internal Medicine, University of Patras, Patras, Greece.; Bila J; Clinic of Hematology, University of Belgrade, Belgrade, Serbia.; Oriol A; Institut Català d'Oncologia, Hospital Germans Trias I Pujol, Barcelona, Spain.; Mateos MV; Hematology Department, University Hospital of Salamanca/IBSAL/Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain.; Einsele H; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.; Orfanidis I; Health Data Specialists S.A., Dublin, Ireland.; Gries KS; Janssen Research & Development, LLC, Seattle, Washington, USA.; Fastenau J; Janssen Research & Development, LLC, Raritan, New Jersey, USA.; Liu K; Janssen Research & Development, LLC, Raritan, New Jersey, USA.; He J; Janssen Research & Development, LLC, Raritan, New Jersey, USA.; Kampfenkel T; Janssen Research & Development, LLC, Leiden, Netherlands.; Qiu Y; Janssen Research & Development, LLC, Beijing, China.; Amin H; Janssen Research & Development, LLC, Raritan, New Jersey, USA.; Carson R; Janssen Research & Development, LLC, Wayne, Pennsylvania, USA.; Sonneveld P; Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, Netherlands.

Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

Plesner T; Vejle Hospital and University of Southern Denmark, Vejle, Denmark.; Dimopoulos MA; National and Kapodistrian University of Athens School of Medicine, Athens, Greece.; Oriol A; Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain.; San-Miguel J; Clinica Universidad de Navarra, Pamplona, Spain.; Bahlis NJ; Tom Baker Cancer Centre, Calgary, AB, Canada.; Rabin N; Department of Haematology, University College London Hospitals NHS Trust, London, UK.; Suzuki K; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan.; Yoon SS; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.; Ben-Yehuda D; Hematology Department, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.; Cook G; University of Leeds, Leeds, UK.; Goldschmidt H; Internal Medicine V, University Hospital Heidelberg and National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Grosicki S; Medical University of Silesia, Katowice, Poland.; Qin X; Janssen Research & Development, Spring House, PA, USA.; Fastenau J; Janssen Global Services, Raritan, NJ, USA.; Garvin W; Janssen Research & Development, Spring House, PA, USA.; Carson R; Janssen Global Services, Raritan, NJ, USA.; Renaud T; Janssen Global Services, Raritan, NJ, USA.; Gries KS; Janssen Global Services, Raritan, NJ, USA.

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

Knop S; Department of Haematology and Oncology, Würzburg University Medical Center, Oberdürrbacher Straße 6, 97080, Würzburg, Germany. knop_s@ukw.de.; Mateos MV; University Hospital of Salamanca-Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.; Dimopoulos MA; National and Kapodistrian University of Athens, Athens, Greece.; Suzuki K; Japanese Red Cross Medical Center, Tokyo, Japan.; Jakubowiak A; University of Chicago Medical Center, Chicago, IL, USA.; Doyen C; Université Catholique of Louvain, CHU UCL Namur, Yvoir, Belgium.; Lucio P; Champalimaud Centre for the Unknown, Lisbon, Portugal.; Nagy Z; Semmelweis University, Budapest, Hungary.; Usenko G; Dnipropetrovsk City Multidisciplinary Clinical Hospital No. 4, Dnipropetrovsk, Ukraine.; Pour L; University Hospital Brno, Brno, Czech Republic.; Cook M; University Hospitals Birmingham NHS Trust, Birmingham, UK.; Grosicki S; Silesian Medical University, Katowice, Poland.; Crepaldi A; Clinica de Tratamento E, Cuiaba, Brazil.; Liberati AM; Azienda Ospedaliera 'Santa Maria', Terni, Italy.; Campbell P; Andrew Love Cancer Centre, Geelong, Australia.; Shelekhova T; Clinic of Professional Pathology, Saratov, Russia.; Yoon SS; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Losava G; LTD 'Medinvent' Institute of Health, Tbilisi, Georgia.; Fujisaki T; Matsuyama Red Cross Hospital, Matsuyama, Japan.; Garg M; Leicester Royal Infirmary, Leicester, UK.; Wang J; Janssen Research and Development, Raritan, NJ, USA.; Wroblewski S; Janssen Research & Development, LLC, Spring House, PA, USA.; Kudva A; Janssen Research and Development, Raritan, NJ, USA.; Gries KS; Janssen Research and Development, Raritan, NJ, USA.; Fastenau J; Janssen Research and Development, Raritan, NJ, USA.; San-Miguel J; Clínica Universidad de Navarra-Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, Centro de Investigación Biomédica en Red de Cáncer, Pamplona, Spain.; Cavo M; Institute of Hematology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.

Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE